609 related articles for article (PubMed ID: 19276344)
21. Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.
Li Y; VandenBoom TG; Kong D; Wang Z; Ali S; Philip PA; Sarkar FH
Cancer Res; 2009 Aug; 69(16):6704-12. PubMed ID: 19654291
[TBL] [Abstract][Full Text] [Related]
22. Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype.
El Amrani M; Corfiotti F; Corvaisier M; Vasseur R; Fulbert M; Skrzypczyk C; Deshorgues AC; Gnemmi V; Tulasne D; Lahdaoui F; Vincent A; Pruvot FR; Van Seuningen I; Huet G; Truant S
Mol Carcinog; 2019 Nov; 58(11):1985-1997. PubMed ID: 31373074
[TBL] [Abstract][Full Text] [Related]
23. Gemcitabine resistance is associated with epithelial-mesenchymal transition and induction of HIF-1α in pancreatic cancer cells.
Wang R; Cheng L; Xia J; Wang Z; Wu Q; Wang Z
Curr Cancer Drug Targets; 2014; 14(4):407-17. PubMed ID: 24575976
[TBL] [Abstract][Full Text] [Related]
24. Activated K-ras and INK4a/Arf deficiency cooperate during the development of pancreatic cancer by activation of Notch and NF-κB signaling pathways.
Wang Z; Banerjee S; Ahmad A; Li Y; Azmi AS; Gunn JR; Kong D; Bao B; Ali S; Gao J; Mohammad RM; Miele L; Korc M; Sarkar FH
PLoS One; 2011; 6(6):e20537. PubMed ID: 21673986
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of gemcitabine-resistant pancreatic tumor cells.
Shah AN; Summy JM; Zhang J; Park SI; Parikh NU; Gallick GE
Ann Surg Oncol; 2007 Dec; 14(12):3629-37. PubMed ID: 17909916
[TBL] [Abstract][Full Text] [Related]
26. Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells.
Nwabo Kamdje AH; Mosna F; Bifari F; Lisi V; Bassi G; Malpeli G; Ricciardi M; Perbellini O; Scupoli MT; Pizzolo G; Krampera M
Blood; 2011 Jul; 118(2):380-9. PubMed ID: 21602525
[TBL] [Abstract][Full Text] [Related]
27. Paracrine HGF promotes EMT and mediates the effects of PSC on chemoresistance by activating c-Met/PI3K/Akt signaling in pancreatic cancer in vitro.
Xu J; Liu S; Yang X; Cao S; Zhou Y
Life Sci; 2020 Dec; 263():118523. PubMed ID: 33039386
[TBL] [Abstract][Full Text] [Related]
28. PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway.
Yao N; Chen Q; Shi W; Tang L; Fu Y
Mol Carcinog; 2019 Jul; 58(7):1291-1302. PubMed ID: 30968979
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermia inhibits the motility of gemcitabine-resistant pancreatic cancer PANC-1 cells through the inhibition of epithelial-mesenchymal transition.
Jin H; Zhao Y; Zhang S; Yang J; Zhang X; Ma S
Mol Med Rep; 2018 May; 17(5):7274-7280. PubMed ID: 29568909
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin II contributes to renal fibrosis independently of Notch pathway activation.
Lavoz C; Rodrigues-Diez R; Benito-Martin A; Rayego-Mateos S; Rodrigues-Diez RR; Alique M; Ortiz A; Mezzano S; Egido J; Ruiz-Ortega M
PLoS One; 2012; 7(7):e40490. PubMed ID: 22792351
[TBL] [Abstract][Full Text] [Related]
31. Targeting the notch ligand JAGGED1 in both tumor cells and stroma in ovarian cancer.
Steg AD; Katre AA; Goodman B; Han HD; Nick AM; Stone RL; Coleman RL; Alvarez RD; Lopez-Berestein G; Sood AK; Landen CN
Clin Cancer Res; 2011 Sep; 17(17):5674-85. PubMed ID: 21753153
[TBL] [Abstract][Full Text] [Related]
32. Up-regulation of MBD1 promotes pancreatic cancer cell epithelial-mesenchymal transition and invasion by epigenetic down-regulation of E-cadherin.
Xu J; Zhu W; Xu W; Yao W; Zhang B; Xu Y; Ji S; Liu C; Long J; Ni Q; Yu X
Curr Mol Med; 2013 Mar; 13(3):387-400. PubMed ID: 23331011
[TBL] [Abstract][Full Text] [Related]
33. Zidovudine, an anti-viral drug, resensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine by inhibition of the Akt-GSK3β-Snail pathway.
Namba T; Kodama R; Moritomo S; Hoshino T; Mizushima T
Cell Death Dis; 2015 Jun; 6(6):e1795. PubMed ID: 26111057
[TBL] [Abstract][Full Text] [Related]
34. Gemcitabine enhances cell invasion via activating HAb18G/CD147-EGFR-pSTAT3 signaling.
Xu BQ; Fu ZG; Meng Y; Wu XQ; Wu B; Xu L; Jiang JL; Li L; Chen ZN
Oncotarget; 2016 Sep; 7(38):62177-62193. PubMed ID: 27556697
[TBL] [Abstract][Full Text] [Related]
35. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells.
Rosati E; Sabatini R; Rampino G; Tabilio A; Di Ianni M; Fettucciari K; Bartoli A; Coaccioli S; Screpanti I; Marconi P
Blood; 2009 Jan; 113(4):856-65. PubMed ID: 18796623
[TBL] [Abstract][Full Text] [Related]
36. The ZEB1/miR-200 feedback loop controls Notch signalling in cancer cells.
Brabletz S; Bajdak K; Meidhof S; Burk U; Niedermann G; Firat E; Wellner U; Dimmler A; Faller G; Schubert J; Brabletz T
EMBO J; 2011 Feb; 30(4):770-82. PubMed ID: 21224848
[TBL] [Abstract][Full Text] [Related]
37. Jagged-Notch signaling ensures dorsal skeletal identity in the vertebrate face.
Zuniga E; Stellabotte F; Crump JG
Development; 2010 Jun; 137(11):1843-52. PubMed ID: 20431122
[TBL] [Abstract][Full Text] [Related]
38. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
Guo Q; Qin W
J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
[TBL] [Abstract][Full Text] [Related]
39. Notch signaling drives multiple myeloma induced osteoclastogenesis.
Colombo M; Thümmler K; Mirandola L; Garavelli S; Todoerti K; Apicella L; Lazzari E; Lancellotti M; Platonova N; Akbar M; Chiriva-Internati M; Soutar R; Neri A; Goodyear CS; Chiaramonte R
Oncotarget; 2014 Nov; 5(21):10393-406. PubMed ID: 25257302
[TBL] [Abstract][Full Text] [Related]
40. Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.
Zhang Z; Duan Q; Zhao H; Liu T; Wu H; Shen Q; Wang C; Yin T
Cancer Lett; 2016 Nov; 382(1):53-63. PubMed ID: 27576197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]